Right test for the right reason: Updates on testing technologies and protocols for COVID-19
On the Use of Rapid Antigen Tests to Confirm COVID-19 Cases: Pursuant to the Inter-Agency Task Force on Emerging Infectious Diseases Resolution No. 106-A authorizing the procurement and use of Rapid Antigen Test Kits in accordance with Department of Health (DOH) Department Memorandum (D.M.) 2020-0468 which provides technical guidance on the use of antigen tests, the DOH shall allow the use of rapid antigen as diagnostic and confirmatory tests for close contacts, and COVID-19 suspect and probable cases in the NCR+ area (Bulacan, Cavite, Laguna, Rizal, and Metro Manila), without the need for Reverse Transcription-Polymerase Chain Reaction (RT-PCR) testing. This is to ensure that the appropriate response and control measures may be immediately initiated by Local Government Units (LGUs) to contain further spread of the virus. On the Inclusion of Rapid Antigen Test-Confirmed Cases in the Total Case Count: Considering the aforementioned development, the DOH shall also include suspect and probable cases and close contacts with positive rapid antigen tests from areas with declared outbreaks—in this case the NCR+ area—as confirmed in the daily case count, as well as in the total case count being reported by the Department. However, reporting of COVID-19 cases shall be disaggregated based on the type of test used. Those cases who tested positive but do not fit the case definition of suspect and probable case or close contact under existing DOH issuances shall be retested using RT-PCR for them to be tagged as a confirmed COVID-19 case...

Inter-Agency Task Force for the Management of Emerging Infectious Diseases Resolution No. 107-A